Q2 2022 Holdings
Filed 2022-08-15 | 27 holdings | $507.8M | 13F-HR/A | View on SEC ↗ · Holdings Table ↗
Amended (2023-05-15) | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Tricida Inc(1T7)A | COM | 89610F101 | $69.0M | 7,132,079 | 13.6% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $63.7M | 4,563,962 | 12.5% |
| Relmada Therapeutics Inc(RLMD)A | COM | 75955J402 | $43.1M | 2,270,072 | 8.5% |
| Travere Therapeutics Inc(TVTX)A | COM | 89422G107 | $41.5M | 1,711,102 | 8.2% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $36.4M | 4,038,117 | 7.2% |
| GH Research PLC(GHRS)A | ORD SH | G3855L106 | $31.8M | 3,185,573 | 6.3% |
| Instil Bio IncA | COM | 45783C101 | $27.7M | 5,997,657 | 5.5% |
| Celldex Therapeutics Inc(CLDX) | COM | 15117B202 | $23.3M | 865,116 | 4.6% |
| Viridian Therapeutics Inc(VRDN)A | COM | 92790C104 | $21.4M | 1,852,919 | 4.2% |
| VistaGen Therapeutics Inc(VTGNUSD)A | COM | 92840H202 | $18.2M | 20,697,286 | 3.6% |
| Marinus Pharmaceuticals Inc(MRNS*)A | COM | 56854Q200 | $15.3M | 3,156,803 | 3.0% |
| Aadi Bioscience Inc(WHWK) | COM | 00032Q104 | $14.5M | 1,173,518 | 2.8% |
| Inozyme Pharma IncA | COM | 45790W108 | $12.9M | 2,709,987 | 2.5% |
| Akouos IncA | COM | 00973J101 | $12.5M | 2,667,119 | 2.5% |
| LianBioA | SPONS ADR | 53000N108 | $11.6M | 5,378,341 | 2.3% |
| Aerovate Therapeutics IncA | COM | 008064107 | $9.2M | 590,408 | 1.8% |
| Trevi Therapeutics Inc(TRVI)A | COM | 89532M101 | $8.6M | 3,050,022 | 1.7% |
| Chinook Therapeutics Inc(290A)A | COM | 16961L106 | $8.6M | 489,618 | 1.7% |
| Annexon Inc(ANNX) | COM | 03589W102 | $7.3M | 1,928,477 | 1.4% |
| Savara Inc(SVRA)A | COM | 805111101 | $6.3M | 4,117,530 | 1.2% |
| Lyra Therapeutics Inc(LYRA)A | COM | 55234L105 | $5.2M | 924,170 | 1.0% |
| Provention Bio Inc(PRVBUSD)A | COM | 74374N102 | $4.5M | 1,118,653 | 0.9% |
| Altimmune Inc(ALT) | COM | 02155H200 | $4.3M | 369,306 | 0.9% |
| aTyr Pharma Inc(ATYR) | COM | 002120202 | $4.0M | 1,398,889 | 0.8% |
| Affimed NVA | COM | N01045108 | $4.0M | 1,428,571 | 0.8% |
| Rallybio CorpA | COM | 75120L100 | $2.0M | 268,532 | 0.4% |
| Xenon Pharmaceuticals Inc(XENE)A | COM | 98420N105 | $913.0K | 30,000 | 0.2% |
| DBV Technologies SA | SPONS ADR | 23306J101 | $46.3K | 9,300,000 | 0.0% |